PYMNTS.com October 22, 2024

Hospitals are adopting AI assistants for patient care and Microsoft is rolling out medical imaging models, while the U.S. Food and Drug Administration (FDA) calls for vigilant monitoring of these rapidly evolving tools. The push toward AI integration promises to ease healthcare worker burnout and improve diagnostics, but regulators warn that these powerful new systems require continuous oversight to ensure patient safety.

FDA Calls for Monitoring of AI Medical Tools

According to a new FDA perspective published in JAMA, the Food and Drug Administration is pushing for continuous monitoring of artificial intelligence tools used in healthcare. The agency warns that unmonitored AI systems could pose risks to patient safety.

The agency, which has authorized nearly 1,000 AI-enabled medical devices to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Health System / Hospital, Provider, Technology
Related Articles:
FDA updates definition of 'healthy'
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
4 takeaways from the FDA’s first digital health advisory committee
FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system
FDA commissioner urges health systems to strengthen AI quality oversight

Share This Article